Insider Trading activities of Adeza Biomedical Corp insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Adeza Biomedical Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Adeza Biomedical Corp since year 2005. Table 2 shows the detailed insider transactions of Adeza Biomedical Corp since 2005. The reporting company's ticker symbol is ADZA. The reporting company's CIK number is 902482.
The total value of stock buying since 2005 is $35,269,728.
The total value of stock sales since 2005 is $4,108,612.
The total value of stock option exercises since 2005 is $37,965.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Adeza Biomedical Corp (ADZA).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2007-03 1,469,572 $35,269,728 0 $0 0 $0
2006-12 0 $0 1,200 $18,000 0 $0
2006-11 0 $0 29,890 $440,578 29,890 $28,993
2006-10 0 $0 1,200 $19,791 0 $0
2006-09 0 $0 1,200 $20,415 0 $0
2006-08 0 $0 1,200 $19,782 0 $0
2006-04 0 $0 4,968 $105,743 1,050 $1,018
2006-03 0 $0 29,228 $548,643 1,200 $1,164
2006-02 0 $0 2,560 $56,606 3,200 $3,104
2006-01 0 $0 4,480 $95,508 3,200 $3,104
2005-12 0 $0 5,193 $97,114 600 $582
2005-11 0 $0 5,477 $94,434 0 $0
2005-08 0 $0 162,297 $2,591,998 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Adeza Biomedical Corp insiders (ADZA)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2007-03-31 Augusta Medical Corp (10% Owner) Buy 1,469,572 24.00 35,269,728
2006-12-06 Hussa Robert O (VP Research & Development) Sale 1,200 15.00 18,000
2006-11-30 Sacco Marian E (VP Sales & Marketing) Sale 29,890 14.74 440,578
2006-11-30 Sacco Marian E (VP Sales & Marketing) Option Ex 29,890 .97 28,993
2006-10-02 Hussa Robert O (VP Research & Development) Sale 1,200 16.49 19,791
2006-09-01 Hussa Robert O (VP Research & Development) Sale 1,200 17.01 20,415
2006-08-08 Hussa Robert O (VP Research & Development) Sale 1,200 16.48 19,782
2006-04-03 Hussa Robert O (VP Research & Development) Sale 4,968 21.28 105,743
2006-04-03 Hussa Robert O (VP Research & Development) Option Ex 1,050 .97 1,018
2006-03-10 Anderson Emory V. (President and CEO) Sale 5,083 19.13 97,222
2006-03-09 Anderson Emory V. (President and CEO) Sale 5,085 18.65 94,814
2006-03-08 Anderson Emory V. (President and CEO) Sale 5,085 18.61 94,621
2006-03-07 Anderson Emory V. (President and CEO) Sale 5,085 18.92 96,223
2006-03-06 Hussa Robert O (VP Research & Development) Sale 3,805 18.66 71,005
2006-03-06 Hussa Robert O (VP Research & Development) Option Ex 1,200 .97 1,164
2006-03-06 Anderson Emory V. (President and CEO) Sale 5,085 18.64 94,758
2006-02-01 Hussa Robert O (Development) Sale 2,560 22.11 56,606
2006-02-01 Hussa Robert O (Development) Option Ex 3,200 .97 3,104
2006-01-03 Hussa Robert O (Development) Sale 3,840 21.57 81,336
2006-01-03 Hussa Robert O (Development) Option Ex 3,200 .97 3,104
2005-12-30 Sacco Marian E (VP Sales & Marketing) Option Ex 600 .97 582
2005-12-01 Hussa Robert O (Development) Sale 5,193 18.70 97,114
2005-11-04 Hussa Robert O (Development) Sale 5,477 17.24 94,434
2005-08-29 Hussa Robert O (Development) Sale 10,000 16.57 165,710
2005-08-23 Credit Suisse First Boston/ (Other) Sale 89,603 15.87 1,422,178
2005-08-10 Anderson Emory V. (President and CEO) Sale 59,241 15.92 942,820
2005-08-08 Hussa Robert O (Development) Sale 3,453 17.75 61,290

Insider trading activities including stock purchases, stock sales, and option exercises of ADZA listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Adeza Biomedical Corp (symbol ADZA, CIK number 902482) see the Securities and Exchange Commission (SEC) website.